Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (865) Cymbalta (duloxetine), Eli Lilly,
...Newly Approved Drug Therapies (865) Cymbalta (duloxetine), Eli Lilly, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Cymbalta (duloxetine) Company: Eli Lilly Approval Status: Approved August 2004 Treatment Area: Depression General Information Cymbalta ...
View Page

2.  News: Cymbalta Reduces Pain in Fibromyalgia Trial (Clinical Trials Today)
...News: Cymbalta Reduces Pain in Fibromyalgia Trial (Clinical Trials Today) Content-Language: en-us description: Eli Lilly reported positive results from a phase III trial of Cymbalta (duloxetine) for the treatment of fibromyalgia. Cymbalta is Lilly’s serotonin and norepinephrine reuptake inhibitor ...
View Page

3.  Study Posting (232) Trial #148599, Multiple Sclerosis, Boulder, CO
...Sclerosis, Boulder, CO Trial Information New medicine for patients with Multiple Sclerosis experiencing Neuropathic Pain Cymbalta in Patients with Central Neuropathic Pain Due to Multiple Sclerosis This five month study is designed to study the effectiveness of Cymbalta compared to placebo in treating neuropathic pain due to Multiple Sclerosis. Major Inclusion/Exclusion Criteria ...
View Page

4.  Study Posting (709) Trial #116328, Depression, Stanford, CA
...purpose of this research is to get information on the effectiveness of switching to duloxetine (Cymbalta) from a selective serotonin reuptake inhibitor (SSRI) to relieve sexual dysfunction in patients with depression ...
View Page

5.  Study Posting (709) Trial #116327, Sexual Dysfunction, Stanford, CA
...purpose of this research is to get information on the effectiveness of switching to duloxetine (Cymbalta) from a selective serotonin reuptake inhibitor (SSRI) to relieve sexual dysfunction in patients with depression ...
View Page

6.  Study Posting (2674) Trial #118895, Generalized Anxiety Disorder (GAD), Maitland, FL
...Anxiety medication. Patient Inclusion Criteria: • Patients must be 18 to 65 years old and taking Cymbalta, Lexapro, Effexor, or Paxil to treat symptoms of anxiety Patient Exclusion Criteria: • Unstable medical illness ...
View Page

7.  Study Posting (5191) Trial #141566, Generalized Anxiety Disorder (GAD), Dallas, TX
...from Generalized Anxiety Disorder Patient Exclusion Criteria: • May not have had a failed treatment of Cymbalta • May not have a history of a previous failure with SSRI and/or SSRI • May ...
View Page

8.  Study Posting (2515) Trial #139041, Fibromyalgia, Deland, FL
...or more of the Fibromyalgia Symptoms Patient Exclusion Criteria • Have been treated with duloxetine or cymbalta • Bipolar disorder • Psychotic disorder • Rheumatoid arthritis • Lupus • Hep B or C • HIV Avail Clinical Research ...
View Page

9.  Study Posting (3777) Trial #152286, Peripheral Neuropathy, Little Rock, AR
...adequate trials with at least 2 of the following: gabapentin (Neurotin), pregabalin (Lyrica) or duloxetine (Cymbalta) • BMI (body mass index) must be 40 or less • No history of severe psychiatric disorder ...
View Page

10.  Study Posting (3777) Trial #152329, Diabetic Neuropathy, Little Rock, AR
...adequate trials with at least 2 of the following: gabapentin (Neurotin), pregabalin (Lyrica) or duloxetine (Cymbalta) • BMI (body mass index) must be 40 or less • No history of severe psychiatric disorder ...
View Page

11.  CenterWatch: New Medical Therapies in Disease Category (117), Parkinson's Disease
...approved by the FDA. Eli Lilly reported positive results from a phase III trial of Cymbalta for the treatment of fibromyalgia. This randomized, placebo-controlled trial enrolled subjects with fibromyalgia, with or without depression, who received Cymbalta (60 mg or 120 mg) or placebo. They were subsequently measured at three and six ...
View Page

12.  CenterWatch: New Medical Therapies in Disease Category (102), Multiple Sclerosis
...approved by the FDA. Eli Lilly reported positive results from a phase III trial of Cymbalta for the treatment of fibromyalgia. This randomized, placebo-controlled trial enrolled subjects with fibromyalgia, with or without depression, who received Cymbalta (60 mg or 120 mg) or placebo. They were subsequently measured at three and six ...
View Page

13.  CenterWatch: New Medical Therapies in Disease Category (218), Fibromyalgia
...approved by the FDA. Eli Lilly reported positive results from a phase III trial of Cymbalta for the treatment of fibromyalgia. This randomized, placebo-controlled trial enrolled subjects with fibromyalgia, with or without depression, who received Cymbalta (60 mg or 120 mg) or placebo. They were subsequently measured at three and six ...
View Page

14.  CenterWatch: Psychiatry/Psychology Approved Drug Therapies
...paliperidone) ; Janssen Pharmaceutica; For the treatment of schizophrenia, Approved December 2006 Drugs Approved in 2004 Cymbalta (duloxetine) ; Eli Lilly; For the treatment of major depressive disorder, Approved August 2004 Drugs Approved ...
View Page

15.  CenterWatch: New Medical Therapies in Disease Category (195), Urinary Incontinence
...in the initial single-blind, placebo controlled phase III study. Duloxetine, under the trade name Cymbalta, was approved this week for the treatment of major depression. September 15, 2003 Eli Lilly ...
View Page

16.  CenterWatch: List of Newly Approved Drug Thearapies
...treatment of alcohol dependence and the maintenance of alcohol abstinence, Approved August, 2004 Psychiatry/Psychology Cymbalta (duloxetine) ; Eli Lilly; For the treatment of major depressive disorder, Approved August 2004 Pulmonary/Respiratory ...
View Page